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Summary
Evidence from animal models and epidemiological studies has linked prenatal alco-
hol exposure (PAE) to a broad range of long-term cognitive and behavioral deficits.
However, there is virtually no information in the scientific literature regarding the
levels of PAE associated with an increased risk of clinically significant adverse
effects. During the period from 1975-1993, several prospective longitudinal cohort
studies were conducted in the U.S., in which maternal reports regarding alcohol use
were obtained during pregnancy and the cognitive development of the offspring was
assessed from early childhood through early adulthood. The sample sizes in these
cohorts did not provide sufficient power to examine effects associated with different
levels and patterns of PAE. To address this critical public health issue, we have devel-
oped a hierarchical meta-analysis to synthesize information regarding the effects of
PAE on cognition, integrating data on multiple endpoints from six U.S. longitudi-
nal cohort studies. Our approach involves estimating the dose-response coefficients
for each endpoint and then pooling these correlated dose-response coefficients to
obtain an estimated ‘global’ effect of exposure on cognition. In the first stage, we use
individual participant data to derive estimates of the effects of PAE by fitting regres-
sion models that adjust for potential confounding variables using propensity scores.
The correlation matrix characterizing the dependence between the endpoint-specific
dose-response coefficients estimated within each cohort is then run, while accom-
modating incomplete information on some endpoints. We also compare and discuss
inferences based on the proposed approach to inferences based on a full multivariate
analysis.
KEYWORDS:
cognition; hierarchical model; multiple outcomes; prenatal alcohol exposure; synthesis of evidence; two-
stage estimation; fetal alcohol syndrome
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1 INTRODUCTION
Meta-analysis is a common approach used to combine quantitative evidence across studies to generate a global exposure/treat-
ment effect that is more precise than estimates obtainable from individual studies alone. Traditionally, this has been achieved
by obtaining summary statistics from published studies and then combining those estimates using methods of meta-analyses.
Although it is cost effective and easy to implement, meta-analyses tend to be underpowered and prone to ecological and con-
founding bias? ? . Individual patient data (IPD) meta-analysis provides a potential solution to avoid such biases, along with
modeling flexibilities such as accounting for the correlation between endpoints and dealing with missing data at the patient
level? . If one has access to the original patient level data, there may be a choice between a fully specified multivariate IPD and
a two-stage IPD approach. The full multivariate approach generally uses mixed-effects multilevel regressions to model between
and within heterogeneity and quantify the effect of interest in a single model. Although this approach is considered flexible, it
may be challenging for conducting and communicating the findings, especially regarding visualization with the hallmark forest
plot. The alternative IPD approach involves modeling the data in two stages. In the first step, study-level estimates are obtained
using separate regression models. In the second step, standard methods of meta-analysis are used to obtain an overall estimate.
An important disadvantage of standard methods of meta-analysis is the assumption that effect size estimates being combined
are independent. This assumption is violated when multiple outcomes are interest for synthesis across studies. To avoid the
dependence of the effect sizes, several ad-hoc methods have been proposed including averaging the effect sizes and selecting
one effect size per study. These ad-hoc approaches may lead to missed opportunities to utilize all available data to address the
relevant research questions? .
More principled approaches have been proposed to deal with correlated effects when conducting IPD meta-analysis. These
advances include multivariate meta-analysis which has been used to jointly synthesize the outcomes observed across studies to
estimate multiple pooled effects simultaneously? . Another approach is the three-level meta analytic model? ? ? , which has been
used to account for dependence of effect sizes within clusters. This approach considers participants to contribute to only one
effect size, so the non-independence is primarily introduced due to the nested structure of the effects? . An additional approach
is based on a two-stage meta-analysis that uses summary measures. In this approach, dependency among effect sizes is handled
via robust variance estimation (RVE) in which the dependence between the endpoints is not explicitly modeled, but instead
the standard errors for the overall treatment effect or meta-regression coefficients are adjusted? . This approach may require
making a reasonable guess about the between outcome correlation to estimate the between-study variance and to approximate
the optimal weights.
In this paper, we propose an innovative approach: a hierarchical meta-analysis for the settings in which each cohort study
provides multiple endpoints, resulting in correlated sampling errors of the estimated effects. The work is motivated by a project
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that involves the integration of data from six longitudinal cohorts, each one using usingmultiple inter-related tests and assessment
tools to measure child cognition. We assume that all endpoints are measuring an effect of exposure on a common underlying
construct A major strength of our approach is that it will enable us to pool data from diverse endpoints within each cohort and
then assess the degree to which consistent patterns emerge across cohorts.
In the proposed approach, we first derive the estimates and the standard errors by fitting univariate regression models for
each separate outcome of interest. In the second stage, we combine the summary measures using a random-effects model. In
this stage, unlike the existing methods of two-stage IPD analysis, we account for the correlated effect sizes within each cohort.
First, some of the endpoints within a cohort were highly correlated causing unstable results. To overcome this problem, we
obtain robust covariance estimates for effect size estimates within cohorts which we use at the second synthesis stage of the
hierarchical meta-analytic approach which not all endpoints was observed for all children within a cohort. To address this issue,
we derived a formula for the pairwise correlation between estimated effects using an adjustment, reflecting the fact that not all
endpoints are observed for all children. To facilitate the creation of forest plots, downloading the results, and view information
about the endpoints included in the analysis in an efficient way, we developed a web-based application which is written using
the Shiny library and is hosted on a server using the open-source Shiny Server software (Rstudio and Inc., 2014). In the last
stage of our hierarchical meta analytic approach, we combine the independent effect size estimates obtained for each cohort in
a random-effects model to obtain a global measure of the effect size across cohorts? ? .
We compare and contrast the findings from proposed approach and a full multivariate analysis to answer a question that nat-
urally arises when results of these two models coincide. Previous studies evaluated this question in different settings. Olkin and
Simpsin? showed that in the case of comparing multiple treatments and a control with respect to a continuous outcome, the
traditional meta-analysis based on estimated treatment contrasts is equivalent to the least squares regression analysis of individ-
ual patient data if there are no study-by-treatment interactions and the error variances are constant across trials. Mathew and
Nordstorm? claimed that the equivalence holds even if the error variances are different across trials. Empirically, meta-analysis
using original data has been found to be generally similar but not identical to meta-analysis using summary statistics. White-
head and Lin and Zeng? ? , showed that for all commonly used parametric and semi-parametric models, there is no asymptotic
efficiency gain by analyzing original data if the parameter of main interest has a common value across studies, the nuisance
parameters have distinct values among studies, and the summary statistics are based on maximum likelihood. More recently
Kontopantelis? conducted a comprehensive simulation study to compare one-stage and two-stage IPD analysis and concluded
that a fully specified one-stage model is preferable especially when investigating interactions. We extend the results from these
existing studies to the setting where there are correlated endpoints across multiple cohorts.
The remainder of the article is organized as follows. In Section 2, we introduce our motivating application based on a meta-
analysis of correlated endpoints measures the effect of prenatal alcohol exposure (PAE) on cognition in six large cohort studies.
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In Section 3, we introduce notation and describe the two-stage analysis and modeling framework used to combine multiple
correlated endpoints within a single cohort. In Section 4, we present the modeling framework used to combine pooled effect size
estimates across cohorts. In section 5, we compare/contrast the proposed approach with the corresponding one-stage approach
via simulation studies. In section 6, we illustrate our method using data from our motivating application. Finally, in section 7,
we discuss the strengths and limitations of our method.
2 MOTIVATING APPLICATION
Evidence from animal models and epidemiological studies has linked PAE to a broad range of cognitive and behavioral deficits,
growth impairment, and physical anomalies, which are known collectively as fetal alcohol syndrome disorders (FASD)? ? ? ? .
Fetal alcohol syndrome (FAS), the most severe of the FASD, is characterized by distinctive craniofacial dysmorphology (small
palpebral fissures, flat philtrum, thin vermillion), small head circumference, and growth retardation? ;? while partial FAS
(PFAS) is diagnosed in the presence of facial dysmorphology, a history of PAE and growth retardation, microcephaly, or central
nervous system (CNS) impairment. Individuals with PAE who lack the characteristic pattern of dysmorphic features but exhibit
cognitive and/or behavioral impairment are often given diagnosis of alcohol-related neurodevelopmental disorder (ARND),
which is the most prevalent FASD. Although the diagnosis of ARND requires a confirmed history of maternal alcohol con-
sumption during pregnancy, there is virtually no information in the scientific literature regarding the levels of PAE associated
with an increased risk of clinically significant adverse effects. In a recently updated set of clinical guidelines? , risky drinking
during pregnancy was defined as 6 or more drinks/week for a 2-week period or 3 or more drinks per occassion consumed on at
least 2 occasions. However, in human studies, there is little empirical evidence of adverse effects at these levels of exposure.
Between 1975 and 1993, the National Institutes of Health (NIH) funded six longitudinal cohort studies in four U.S. cities
(Seattle, Atlanta (two cohorts), Pittsburgh (two cohorts), and Detroit); these are described briefly in Section 1.2. In all but
one of these studies, mothers were recruited and interviewed prospectively about their alcohol use during pregnancy and their
children were followed longitudinally from infancy through young adulthood; the Atlanta 2 study? recruited the mothers shortly
following delivery, interviewed them about their drinking during pregnancy, and followed the children as in the other studies.
All six studies had measured a variety of neurodevelopmental endpoints that assess five specific measures of cognitive function:
IQ, executive function, academic achievement, and learning and memory.
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2.1 The Six Cohort Studies
2.1.1 Seattle Cohort? birth years: 1975-76
All women who were enrolled in prenatal care by the 5th month of pregnancy at two large Seattle hospitals were eligible to
participate. To ascertain PAE, participatingmothers (N = 1529)were administered a Quantity-Frequency-Variability interview?
regarding alcohol, tobacco, and drug use for two time periods: during pregnancy and just prior to pregnancy recognition. 462
newborns were selected based on an algorithm derived from maternal absolute alcohol (AA)/day, alcohol use/occasion, volume
variability, and frequency of intoxication constructed to over-represent infants born to heavier drinkers. Controls included both
abstainers and light drinkers. Infants were followed up at 8 and 18 months and 4, 7, 11, 14, 21, 25, and 30 years. Although
cohort retention was high (e.g., 82% at 14 years), other children not initially selected whose mothers had been interviewed during
pregnancy were added at follow- up assessments to keep the sample size close to 500 at each examination.
2.1.2 Atlanta Cohort 1? birth years: 1980-86
527 low socioeconomic status (SES), pregnant women were recruited at their first prenatal visit at an urban Atlanta hospital
serving a primarily African American, low income population. Women who reported drinking at least 1 oz AA/week during
pregnancywere recruited.Nondrinkers,whowere similar in demographic background,were recruited at the same time to serve as
controls. Women were interviewed at recruitment about their alcohol and drug use; the majority reported drinking on weekends
in a âĂŸbingeâĂŸ pattern. Infants were evaluated following birth. Sub-samples were followed up at 6 and 12 months and 7,
14, and 22 years.
2.1.3 Atlanta Cohort 2? birth years: 1992-1994
306 mothers and their infants were recruited shortly after delivery at an urban Atlanta hospital. 111 reported having drunk
alcohol during pregnancy, 71 of whom also had used cocaine (based on self-report or urine screen); 44 used cocaine but no
alcohol; 151 did not drink alcohol or use cocaine. All participants were English speaking, 19 years or older, and had singleton
births; most were African American and low SES. The infants were assessed at 2 and 8 years.
2.1.4 Pittsburgh Cohort 1? birth years: 1983-86
Participants were recruited from the prenatal clinic at a maternity hospital if they were English-speaking, age 18 or older, and
in their 4th or 5th gestational month. A total of 1360 women were interviewed regarding their usual, maximum, and minimum
consumption of beer, wine, liquor, tobacco, marijuana, and other illicit drugs prior to pregnancy and during the first trimester.
Two cohorts were selected: (1) women who drank 3 or more drinks/week in the first trimester and a random sample of women
who drank less or abstained, and (2) women who used marijuana at least twice/month in the first trimester and a random sample
6 Akkaya Hocagil ET AL
of those who used less or abstained. Because women could be selected for either or both cohorts, there was a 48% overlap. The
cohorts were combined for this analysis: The birth sample consisted of 763 live singleton infants. The alcohol, tobacco, and
drug use interview was repeated in the 7th gestational month and at delivery, when second and third trimester substance use
information was obtained. The cohort consisted of women who were predominantly low income and of fairly equal numbers of
Caucasian and African American women. Participants were followed up at 8 and 18 months, and 3, 6, 10, 14, 16, and 22 years.
2.1.5 Pittsburgh Cohort 2? birth years: 1988-93
English-speaking women in their 4th or 5th month of pregnancy attending the prenatal clinic at a large inner-city hospital
who were 18 years old or older were interviewed regarding their usual, maximum, and minimum consumption of cocaine,
alcohol, marijuana, tobacco, and other drugs prior to pregnancy and during the 1st trimester. Every woman who reported any
cocaine/crack use during the first trimester was enrolled in the study cohort, as was the next woman interviewed who reported
no cocaine or crack use during both the year prior to pregnancy and the first trimester. Although crack/cocaine use was the
criterion for recruitment, a large proportion of these women also drank moderate-to-heavy levels of alcohol; some of the adverse
effects subsequently seen on development were independently attributable to the alcohol exposure. The alcohol and drug use
interview was repeated at the end of the second and third trimesters, and offspring were assessed at 1, 3, 7, 10, 15, and 21 years.
The birth cohort consisted of 295 women and infants; the women were predominantly of low socioeconomic status and were
roughly equally divided by Caucasian and African American race.
2.1.6 Detroit Cohort? birth years: 1986-89
All women (N > 6400) enrolling in the antenatal maternity clinic at a large, inner-city hospital were interviewed regarding
their alcohol use at their first prenatal visit (M = 23.4 wk gestation; SD=7.9), using a timeline follow-back interview? . The
mother provided detailed information about her alcohol consumption on a day-by-day basis during the previous 2 weeks with
recall linked to specific times of day and activities and was also asked to recall her day-by-day drinking during a typical week
around time of conception. Moderate and heavy drinking women were overrepresented in the sample by including all women
reporting at least 0.5 oz AA at conception and a random sample of approximately 5% of the lower level drinkers and abstainers.
The 2-week timeline follow-back interview was repeated at each prenatal clinic visit (M = 5.4 visits). To reduce the risk that
alcohol might be confounded with cocaine exposure, 78 heavy cocaine (<2 days/wk), light alcohol (<7 drinks/wk) users were
also included in the final sample, which consisted of 480 pregnant women and their children. Participants were followed up at
6.5, 12, and 13 months and 7, 14, and 19 years.
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3 NOTATION AND MODEL FORMULATION
Let 푌푖푗푘 be the random variable representing response 푘 for individual 푗 in cohort 푖, 푘 = 1,… , 퐾 , 푗 = 1,… , 퐽푖, where 퐽푖 is the
number of individuals in cohort 푖, 푖 = 1,… , 퐼 . Let 퐴푖푗 be the exposure of interest (i.e. prenatal alcohol exposure) for individual
푗 in study 푖 and 푆푖푗 be their corresponding propensity score.
푌푖푗푘 = 훼푖푘 + 퐵푖푘 퐴푖푗 + 훾푖푘 푆푖푗 + 퐸푖푗푘 , (3.1)
where퐵푖푘 is the effect of a one-unit increase in 퐴푖푗 (alcohol volume) on the mean for response 푘 in cohort 푖 given the propensity
score 푆푖푗 , 푗 = 1,… , 퐽 , 푘 = 1,… , 퐾 , 푖 = 1,… , 퐼 . The propensity score is calculated separately for each cohort in our setting
since the sets of covariates measured differ between cohorts? . We assume here that conditioning on the propensity score renders
the exposure variable independent of all confounders and so that it is sufficient to condition on 푆푖푗 rather than the confounders
themselves? .
The parameter 훾푖푘 characterizes the effect of the propensity score for a given level of alcohol exposure and 퐸푖푗푘 is the error
term which has mean zero and variance 휎2
푖푘
, 푘 = 1,… , 퐾 , 푖 = 1,… , 퐼 .
We suppose that the effects 퐵푖푘 vary about some average exposure effect, with,
퐵푖푘 ∼ 푁(훽푖, 휙푖) , (3.2)
where 훽푖 is the exposure effect for cohort 푖 and 휙푖 represents the heterogeneity of the response-specific exposure effects for
cohort 푖.
Across cohorts, we suppose that the average exposure effects 훽푖 vary about some average exposure effect, with,
훽푖 ∼ 푁(훽표, 휂
2) , (3.3)
where 훽표 represents the “average effect” of a one-unit increase in the exposure across all cohorts, and is our parameter of ultimate
interest. The variance 휂2 in (3.3) reflects the extent of heterogeneity of the cohort-specific exposure effects.
In the next two subsection, we describe a two-stage approach to estimation and inference with data from a single cohort and in
Section 4, we show how to synthesize cohort-specific exposure effects to obtain an estimate for the average effect of a one-unit
increase in the exposure across all cohorts.
3.1 Stage I Estimation for a Single Cohort
In this section, we temporarily omit the subscript 푖 and describe a two-stage approach to estimate the average exposure effect
for a single cohort where the effects are correlated. Before model fitting we standardize the responses so that they have the same
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first two moments as the Full-Scale IQ variable which has a mean of 100 and a standard deviation of 15. By conducting this
standardization the exposure effects can be expressed in terms of the decrement in IQ associated with a one-unit increase in
prenatal alcohol exposure? .
For the first stage, we fit separate linear models for each response, assuming
푌푗푘 = 훼푘 + 퐵푘 퐴푗 + 훾푘 푆푗 + 퐸푗푘 , (3.4)
where 퐵푘 is the effect of a one-unit increase in 퐴푗 (alcohol volume) on the mean for response 푘, given the propensity score 푆푗 ,
푗 = 1,… , 퐽 , 푘 = 1,… , 퐾 . The parameter 훾푘 characterizes the effect of the propensity score for a given level of alcohol exposure
and 퐸푗푘 is the error term which has mean zero and variance 휎
2
푘
, 푘 = 1,… , 퐾 .
We suppose that the effects 퐵푘, 푘 = 1,… , 퐾 vary about some average exposure effect, with
퐵푘 ∼ 푁(훽, 휙), (3.5)
independently and identically distributed and 훽 is the average exposure effect. The variance휙 reflects the extent of heterogeneity
of the response-specific exposure effects for a single cohort.
If we let 푋푗푘 = (1, 퐴푗 , 푆푗)
′ be the covariate vector, we can be write
푌푗푘 = 푋
′
푗푘
휃푘 + 퐸푗푘 (3.6)
where 휃푘 = (훼푘, 퐵푘, 훾푘)
′. We assume 퐸푗푘 ⟂ (퐴푗 , 퐵푘, 푆푗) with 퐸푗푘 ∼ 푁(0, 휎
2
푘
) are i.i.d. for 푗 = 1,… , 퐽 , 푘 = 1, 2,… , 퐾 .
Note that 푋푗푘 does not vary by response type since the exposure variable 퐴푗 and the propensity score 푆푗 are individual level
covariates, but we retain this notation for generality.
We next define 퐾 × 1 vectors 푌푗 = (푌푗1, 푌푗2,… , 푌푗퐾 )
′, 훼 = (훼1,… , 훼퐾 )
′, 퐵 = (퐵1,… , 퐵퐾 )
′ and 훾 = (훾1,… , 훾퐾 )
′ and a
퐾 × 3퐾 covariate matrix
푋′
푗
=
⎡⎢⎢⎢⎢⎢⎢⎢⎣
푋′
푗1
0 0 ⋯ 0
0 푋′
푗2
0 ⋯ 0
⋮ ⋱ 0
0 ⋯ 0 0 푋′
푗퐾
⎤⎥⎥⎥⎥⎥⎥⎥⎦
, (3.7)
where the 0s in this matrix refer to 3 × 1 vectors of 0s. The model given by (3.6) can then be represented in a unifying model
푌푗 = 푋
′
푗
휃 + 퐸푗 (3.8)
where 휃 = (휃′
1
,… , 휃′
퐾
)′ is a 3퐾 × 1 vector of parameters, 퐸푗 = (퐸푗1,… , 퐸푗퐾 )
′ and 퐸푗 ∼ 푁(0,Σ), where Σ is a 퐾 × 퐾
covariancematrix with diagonal entriesΣ푘푘 = 휎
2
푘
= var(퐸푗푘). The off-diagonal entriesΣ푘푙 = 휎푘푙 = cov(퐸푗푘, 퐸푗퓁) accommodate
a conditional dependence (given 푋푗푘, 푋푗푙, 퐵) between the responses from the same individual.
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In the second stage of estimation these estimates are pooled over to obtain a single estimate of the global measure of the causal
effect denoted by 훽 in (3.2). We begin the second stage by estimating the covariance between the errors cov(퐸푗푘, 퐸푗푙) = 휎푘푙,
푙 ≠ 푘 = 1,… , 퐾 , characterizing the dependence between the stage I estimators 휃̂1,… , 휃̂퐾
The challenge in estimating the covariance between the errors cov(퐸푗푘, 퐸푗푙) = 휎푘푙, 푙 ≠ 푘 = 1,… , 퐾 is that not all individuals
contribute data for all responses. To accommodate this fact, we introduce the indicators푅푗푘 = 퐼(푌푗푘 is observed), 푘 = 1,… , 퐾 ,
and assume that the responses are missing at random (MAR) according to Little and Rubin (2019).
If 푆푗푘(휃푘) = 푋푗푘(푌푗푘−푋
′
푗푘
휃푘) is the desired contribution from individual 푗 to the score function for 휃푘 given퐵, the observed
data score equation for estimating 휃푘 at stage I can be written as
푆푘(휃푘) =
퐽∑
푗=1
푅푗푘푆푗푘(휃푘) = 0 , (3.9)
the solutions to which are
휃̂푘 =
퐽∑
푗=1
푅푗푘 (푋푗푘푋
′
푗푘
)−1푋푗푘 푌푗푘 , 푘 = 1,… , 퐾 . (3.10)
The maximum likelihood estimate of 휎2
푘
is
v̂ar(퐸푗푘) = 휎̂
2
푘
=
∑퐽
푗=1
푅푗푘 (푌푗푘 −푋
′
푗푘
휃̂푘)
2
푛푘
(3.11)
where 푛푘 =
∑퐽
푗=1
푅푗푘 is the number of individuals contributing to the estimation of 휃푘, 푘 = 1, 2,… , 퐾 . We also obtain the
maximum likelihood covariance estimate as
ĉov(퐸푗푘, 퐸푗푙) = 휎̂푘푙 =
∑퐽
푗=1
푅푗푘푅푗푙 (푌푗푘 −푋
′
푗푘
휃̂푘) (푌푗푙 −푋
′
푗푙
휃̂푙)
푛푘푙
(3.12)
where 푛푘푙 =
∑퐽
푗=1
푅푗푘푅푗푙, which is consistent under a missing at random assumption
? . We then let Σ̂ denote the estimated
covariance matrix for the errors where 휎푘푙 are adjusted for missing data as
ĉov(퐸푗푘, 퐸푗푙)푎푑푗푢푠푡푒푑 =
휎̂푘푙 푛푘푙
푛푘 푛푙
(3.13)
where 푛푘 =
∑퐽
푗=1
푅푗푘 and 푛푙 =
∑퐽
푗=1
푅푗푙 are the number of individuals contributing to the estimation of 휃푘 and 휃푙 respectively.
More details regarding the derivation of the dependence between the estimates 휃̂푘 and 휃̂푙 are provided in the appendix.
3.2 Stage II: Synthesis across Responses within a Cohort
To consider the synthesis of estimators across all responses we note that
퐸(퐵̂푘 − 훽) = 퐸{(퐵̂푘 − 퐵푘) + (퐵푘 − 훽)} = 0
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so 퐵̂ is comprised of 퐾 dependent unbiased estimators of 훽. Thus
퐵̂ ∼ MVN(휇(훽),Ψ(휙)) (3.14)
asymptotically, where 휇(훽) is a 퐾 × 1 vector with each element equal to 훽. If we let Ψ̂(휙) = 퐽−1 Γ̂ + Δ휙 then based on (3.14)
we may specify a pseudo-likelihood 푃퐿(훽, 휙) for (훽, 휙) given by
푃퐿(훽, 휙) ∝
1
(2휋)퐾∕2
√
Ψ̂(휙)| exp
(
−
1
2
(퐵̂ − 휇(훽))′ Ψ̂−1(휙) (퐵̂ − 휇(훽))
)
. (3.15)
Note that (3.15) could be maximized with respect to (훽, 휙), but we proceed in a computationally convenient iterative approach
based on (3.15). Given an estimate 휙(푟) we compute an estimate 훽(푟) based on a linear combination of 퐵̂1,… , 퐵̂퐾 . The most
efficient linear estimator of 훽 has the form
훽̂ = [1′ [Ψ(휙)]−1 퐵̂]∕[1′ [Ψ(휙)]−1 1] , (3.16)
so we replace Ψ(휙) with an estimator Ψ̂(휙(푟)) = 퐽−1 Γ̂ +Δ휙(푟). We could invert Ψ̂(휙(푟)) but in practice it may be difficult and
while a generalized inverse could be used, the weights resulting from this approachwere often found to vary greatly in magnitude
and even in sign. We therefore adopted an alternative more stable linear estimate using inverse variance weights, whereby we
replaceΨ(휙) with 푑푖푎푔(퐽−1 Γ̂푘푘+휙
(푟) , 푘 = 1,… , 퐾) in (3.16) to obtain 훽̂(푟). We then maximize 푃퐿(훽̂푟, 휙) with respect to 휙 to
obtain 휙(푟+1), with which we recompute 훽̂(푟+1) and repeat iteratively until convergence; we let (훽̂, 휙̂) denote the estimates upon
convergence. A robust variance estimate is then obtained for 훽̂ based on Ψ̂(휙̂)which is given by v̂ar(훽̂) = [핀′ Ψ̂(휙̂) 핀]−1. When we
consider data from multiple cohorts we reintroduce the subscript 푖 and write the corresponding estimates for cohort 푖 as 훽̂푖 and
푉̂푖(훽̂푖) = v̂ar(훽̂푖) = [핀
′ Ψ̂푖(휙̂푖) 핀]
−1 (3.17)
respectively, 푖 = 1,… , 퐼 .
3.3 An Alternative One-Stage (Fully Specified Multivariate) Approach
Note that the parameters estimated according to the hierarchical meta-analytic approach can alternatively be fitted in one-step
via software for fitting hierarchical mixed effect linear models. To do so we define퐾−1 covariates 푇푗푘푟 = 퐼(푘 = 푟), 푟 = 2,… , 퐾
which indicates the outcomes is for response 푘, 푘 = 2,… , 퐾 . We may put these 퐾 − 1 indicators in vector format and define
the (퐾 − 1) × 1 vector 푇푗푘 = (푇푗푘2,… , 푇푗푘퐾)
′. We consider the response for verbal IQ as the reference type and let 푇푖푘2 = 1 for
performance IQ, 푇푖푘3 = 1 for freedom from distractibility (Table 2). Then we fit the model
푌푗푘 = 훼1 + 퐵푘 퐴푗 + 훾1 푆푗 + 휏
′ 푇푗푘 + 휁
′ 푆푗 푇푗푘 + 퐸푗푘 , 푘 = 1,… , 퐾 .
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where 휏 = (휏2,… , 휏퐾)
′ and 휁 = (휁2,… , 휁퐾 )
′ are (퐾 − 1) × 1 vectors with 휏푟 = 훼푟 − 훼1 and 휁푟 = 훾푟 − 훾1, 푟 = 2,… , 퐾 . We
assume퐵푘 ∼ 푁(훽, 휙) as specified in (3.2) where퐵푘 is the effect of a one-unit increase in퐴푗 on the mean of response 푘 given the
propensity score 푆푗 , 훽 is the parameter of ultimate interest representing the “average causal effect” of a one-unit increase in the
exposure across all responses within the cohort, and 휙 characterizes the degree of heterogeneity in the effect across responses.
We also assume 퐸푗 = (퐸푗1,… , 퐸푗퐾 )
′ is a 퐾 × 1 error term with 퐸푗 ∼ MVN(0,Σ) with Σ a 퐾 × 퐾 covariance matrix as in
Section 3.1. The one-step approach involves simultaneous estimation of all fixed effects, 훽, 휙 and Σ at once. This can be fitted
using software for fitting hierarchical linear mixed effects models. We let 훽̃푖 denote the estimate of 훽푖 obtained from fitting
the hierarchical model to the data from cohort 푖 and 푉̃푖(훽̃푖) denote the correspondign variance estimate based on the observed
information matrix, 푖 = 1,… , 퐼 .
4 SYNTHESIS ACROSS COHORTS
In the previous section, we described methods for synthesizing data across multiple outcomes to obtain estimates of the global
causal effect based on a two-stage approach and based on fitting a hierchical mixed effect model. These methods were based on
analyzing data from a single cohort. Here, we describe how to combine cohort-specific estimates to obtain a an overall estimate
of a causal effect while accommodating possible heterogeneity. The approach described in Section 3.2 is an extension of the
approach described by Viechtbauer and implemented in the metafor package? which deals with independent estimates; Section
3.2 adapted the methods to deal with dependent effect estimates so what follows is a simplification of the approach for the last
stage of the data synthesis. We describe it briefly as follows.
We consider 훽푖 as the global causal effect of exposure in cohort 푖 reflecting the impact of an increment in the volume of
prenatal alcohol exposure on the common underlying construct; we let 훽̂푖 be the corresponding estimate. Note that the studies
draw individuals from different populations and so the composition of the samples varies across cohorts. Moreover, the methods
used to measure exposure along with the precise nature of the outcomes differ between studies, even though they were measuring
the same latent attributes regarding cognition. We therefore wish to accommodate a component of variation between studies
(heterogeneity) for the true effects which we accomplished by use of a random effects model of the form
훽̂푖 = 훽푖 + 휖푖 (4.1)
훽푖 = 훽◦ + 푢푖 (4.2)
where we let 휖푖 ∼ 푁(0, 푉̂푖(훽̂푖)) reflect the sampling variation of the estimator from cohort 푖 about the true effect 훽푖, and 푢푖 ∼
푁(0, 휂2) reflects the heterogeneity of the global cohort-specific causal effects across studies. The parameter 훽◦ represents the
overall global effect which is the parameter of ultimate interest. Through this variance decomposition then upon introducing the
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heterogeneity between studies we have v̂ar(훽̂푖) = 푉̂푖(훽̂푖) + 휂
2. The synthesis is achieved in a simlar spirit to Section 3.2 whereby
we consider a pseudo-likelihood of the form
푃퐿(훽◦, 휂) ∝
퐼∏
푖=1
⎧⎪⎨⎪⎩
1
(2휋)퐼∕2
√
(푉̂푖(훽̂푖) + 휂
2)
exp
(
−
(훽̂푖 − 훽◦)
2
2(푉̂푖(훽̂푖) + 휂
2)
)⎫⎪⎬⎪⎭ . (4.3)
The pooled exposure effect estimate 훽̂◦ is obtained as a weighted average of the 훽̂푖 terms with cohort weights equal to the inverse
of 푉̂ (훽̂푖) + 휂̂
2 where 휂̂2 is obtained as the solution to iteratively maximizing (4.3). The R package ‘metafor’ can be used to carry
out this final stage of the data synthesis. If the linear model of Section 3.3 is used for simultaneous estimation of the overall
causal effect then 훽̃푖 and 푉̃푖(훽̃푖) can be used in a similar fashion to obtain the estimator 훽̃표.
5 SIMULATION STUDIES
For the simulation studies, we consider 푘 correlated continuous endpoints from a single study. We generated outcomes from the
following linear regression model:
푌푗푘 = 훼푘 + 훽푘푋푗 + 훾푘푍푗 + 퐸푗푘 , (5.1)
where 푌푗푘 be the random variable representing response k for individual j, k = 1,...,K, j = 1,...,J, and 훽푘 is the effect of a
one-unit increase in 푋푗 on the mean for response 푘 given the covariate 푍푗 . We let 훽푘 vary about some average exposure effect
within a study, with 훽푘 ∼ 푁(훽, 휏
2). The parameter 훾푘 characterizes the effect of the covariate for a given level of exposure,푋푗 .
We also assume 퐸푗 = (퐸푗1,… , 퐸푗퐾 ) is a 퐾 × 1 error term with 퐸푗 ∼ 푀푉푁(0,Σ) with Σ a 퐾 × 퐾 covariance matrix. The
simulations were performed in different scenarios. We generated the effect size for the exposure, 훽푘 from normal distribution
with mean 3 and variance 휏2. Scenarios were created by manipulating the number of outcomes (k) and, varying between-study
heterogeneity (휏2). We consider the scenarios where the number of outcomes is equal to 3, 5, and 10 and 휏2 takes the values
0.10,0.25 and 0.50. For each combination of the simulation parameters, we generated 1000 datasets with the sample size of 500
for each endpoint. For each dataset, we performed the two types of meta-analysis, i.e. the one based on the proposed approach
versus the full multivariate analysis.
We evaluated the performance of the proposed approach in simulation settings previously described, over 1000 iterations. The
estimates of interest were the average exposure effect 훽. To allow for a comprehensive comparison, performance was assessed
on a range of metrics: empirical mean bias (EBIAS), average model based standard error (ASE), empirical standard error (ESE)
and coverage probability (CP). The results are summarized in Table 1. Patterns of empirical mean bias were very low and
comparable for the two methods, with the exception of larger between heterogeneity and smaller number of outcomes. In those
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particular scenarios, the proposed approach was the best performer. Coverage probability for the proposed method was about to
the nominal 0.95 for all scenarios considered in this paper .
6 PRENATAL ALCOHOL EXPOSURE AND COGNITIVE FUNCTION IN CHILDREN
For this paper we used data from six large cohort studies to assess the effects of PAE on IQ, which is a measure of cognitive
function. The proposed hierarchical meta-analytic approach is well-suited to assess the effect of PAE on IQ measure since it
enables us to pool data from diverse, correlated endpoints across cohorts. Table 2 lists the endpoints by cohort considered in
this paper. To yield sufficiently precise estimates of effect size, we considered a broad set of potential confounders when fitting
separate linear models for each endpoint. Since each cohort provided a somewhat different set of control variables, we employed
a propensity score approach to adjust for potential confounders (? ). We estimated the propensity score for each cohort separately
and included the propensity score in the linear model as an additional covariate as in model (3.1).
For each outcome k, 훽푘 was estimated from model (3.1). Table 3 lists the estimated effect size and standard errors from
the first stage of the hierarchical meta-analytic approach. The aim of the second stage of the proposed methods is to pool the
estimates of the PAE and estimate the cohort specific overall true mean effect 훽푖 while adjusting for the fact that endpoints are
correlated within a cohort and accommodating incomplete information on some endpoints. Table 4 shows the estimated effect
sizes and standard errors for each cohort. To compare and contrast the results obtained from our method, we conducted a fully
specified multivariate analysis to estimate a pooled effect size for each cohort study using SAS procedure ‘proc mixed‘ . Table
4 shows the estimated effect sizes for each cohort obtained from the fully specified multivariate model. Both methods provided
impressively similar estimates for the effect sizes and the standard errors. Although the difference was not substantial, these two
methods provided slightly different estimates for the between endpoints heterogeneity.
To combine the independent effect size estimates across cohorts and obtain a global effect size estimate of PAE on IQ at age 7
years, we used the R package “metafor" to pool the estimates resulting from our hierarchical meta-analysis and the fully specified
multivariate model. Table 5 provides the estimated effect size of the PAE on childhood IQ across cohorts. The resulting global
effect sizes from the two methods were almost identical.
7 DISCUSSION
In this paper, we have proposed an extension of the standard procedure for two-stage IPD meta-analysis. Our procedure follows
the same steps as conventional methods for two-stage IPD analysis for making inference about the effect size but extends these
analyses by accounting for the correlation between endpoints and by accommodating incomplete data on some endpoints.
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Our approach has several advantages over the one-stage IPD meta-analysis. Firstly, it builds upon the two-stage IPD meta-
analysis that practitioners are already familiar with. Secondly with our approach, one can create forest plots to visualize the
estimated effect sizes for each endpoint. Thirdly, our approach is less likely to encounter convergence problems compared to
the one-stage IPD meta-analysis. Finally, our approach uses the known within study variances, which helps obtain more precise
estimates.
We evaluated and compared our approach with a fully specified multivariate analysis. In simulation scenarios considered
in this paper, we observed that the proposed approach can successfully reduce bias relative to the fully specified multivariate
approach. Our simulation results suggest that, when the number of endpoints is small and the between endpoints variance is
large, our proposed approach outperforms the multivariate analysis.
We illustrated our approach using data on childhood IQ from six cohorts. We analyzed 18 outcomes from the six cohorts.
For our data application, it was important to adjust for the fact that endpoints within a cohort are correlated and some of the
endpoints have incomplete data. To obtain a global effect size estimate, we conducted a hierarchical meta-analysis. In the first
stage, we obtained effect size estimates for each endpoint separately. In the second stage, we employed our proposed approach
to obtain cohort-specific pooled effect size estimates while adjusting for between-endpoint correlation and incomplete data. In
the last stage, we combined effect sizes across the cohorts employing a random-effects model. We compared the results from
our approach with the results from the fully specified multivariate approach. In this comparison, our method performed well
and thus provides an useful innovative tool for performing and interpreting meta-analyses with the correlated effect sizes.
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TABLE 1 Results of a simulation study assessing the performance of our hierarchical meta-analysis and a full multivariate analysis in a variety of settings
Hierarchical Meta-Analytic Approach One-stage (full multivariate) approach
휏2 k EBIAS ASE ESE CP EBIAS ASE ESE CP
0.10
10 0.0070 0.16 0.14 0.96 0.0000 0.10 0.14 0.92
5 0.0060 0.20 0.20 0.96 0.0001 0.13 0.14 0.99
3 0.0090 0.23 0.25 0.95 0.0009 0.14 0.14 0.93
0.25
10 0.0003 0.11 0.10 0.95 0.02 0.18 0.24 0.88
5 0.0002 0.13 0.13 0.95 0.03 0.19 0.21 0.91
3 0.0100 0.15 0.15 0.95 0.02 0.21 0.23 0.94
0.50
10 0.0040 0.16 0.15 0.95 0.04 0.26 0.29 0.96
5 0.0090 0.21 0.20 0.94 0.06 0.27 0.30 0.97
3 0.0100 0.23 0.24 0.94 0.12 0.31 0.34 0.92
EBIAS: Empirical bias, ASE: Average model based standard error, ESE: Empirical standard error, CP: Coverage probability
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TABLE 2 IQ Related Outcomes Assessed at Age 7 in the Six Cohorts
Cohort Endpoints
Seattle
WISC Verbal IQ
WISC Performance IQ
Atlanta 1
Kaufman ABC Simultaneous processing
Kaufman ABC Sequential processing
Atlanta 2
DAS Verbal standard score
DAS Nonverbal standard score
DAS Spatial standard score
Pittsburgh 1
Stanford-Binet Verbal reasoning
Stanford-Binet Abstract reasoning
Stanford-Binet Quantitative reasoning
Stanford-Binet Short-term memory
Pittsburgh 2
Stanford-Binet Verbal reasoning
Stanford-Binet Abstract reasoning
Stanford-Binet Quantitative reasoning
Stanford-Binet Short-term memory
Detroit
WISC Verbal IQ
WISC Performance IQ
WISC Freedom from distractibility
TABLE 3 Summary statistics of IQ related outcomes assessed at age 7
Stage I
Cohort Response type Estimated effect size SE
Detroit WISC Verbal IQ -4.2 3.2
Detroit WISC Performance IQ -3.7 3.2
Detroit WISC Freedom from distractibility -10.3 3.1
Seattle WISC Verbal IQ -0.5 2.6
Seattle WISC Performance IQ -1.9 2.6
Atlanta Cohort 1 Kaufman ABC Simultaneous processing -6.9 2.9
Atlanta Cohort 1 Kaufman ABC Sequential processing -1.9 2.9
Atlanta Cohort 2 DAS Verbal standard score -5.9 3.2
Atlanta Cohort 2 DAS Nonverbal standard score 1.7 3.3
Atlanta Cohort 2 DAS Spatial standard score -0.9 3.3
Pittsburgh Cohort 1 Stanford Binet Verbal reasoning -5.8 3.0
Pittsburgh Cohort 1 Stanford Binet Abstract reasoning -5.0 3.0
Pittsburgh Cohort 1 Stanford Binet Quantitative reasoning -1.9 3.0
Pittsburgh Cohort 1 Stanford Binet Short term memory -5.3 3.0
Pittsburgh Cohort 2 Stanford Binet Verbal reasoning -0.3 3.1
Pittsburgh Cohort 2 Stanford Binet Abstract reasoning -1.8 3.0
Pittsburgh Cohort 2 Stanford Binet Quantitative reasoning -1.1 3.1
Pittsburgh Cohort 2 Stanford BinetÂăShort term memory -3.5 3.1
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TABLE 4 Pooled effect size estimates of prenatal alcohol exposure for each cohort
Stage II
Hierarchical Meta Analytic Approach Full Multivariate Approach
Cohort Effect Size SE 휏̂2 Effect Size SE 휏̂2
Detroit -6.1 3.2 7.8 -6.1 3.1 6.2
Seattle -1.2 2.3 0.0 -1.2 2.3 0.0
Atlanta Cohort 1 -4.4 3.0 5.1 -4.4 3.4 6.2
Atlanta Cohort 2 -1.9 3.0 7.8 -2.0 3.2 8.2
Pittsburgh Cohort 1 -4.3 2.4 0.0 -4.0 2.6 0.0
Pittsburgh Cohort 2 -1.6 2.5 0.0 -1.6 2.5 0.0
TABLE 5 Estimated effects size of prenatal alcohol exposure on IQ at age 7
Stage III
Method Global effect size SE 휏̂2(se)
Hierarchical Meta-Analytic Approach -3.2 0.8 1.0 (2.3)
One-stage (full multivariate approach) -3.1 0.8 0.9 (2.3)
18 Akkaya Hocagil ET AL
APPENDIX
Derivation of the covariance matrix for 퐵̂ The expression for the covariance between 휃̂푘 and 휃̂푙 is obtained based on a general
formula for robust variance estimation. If we stack the score function in (3.9) we obtain 푆(휃) = (푆′
1
(휃1),… , 푆
′
퐾
(휃퐾 ))
′. Then
given 퐵 = (퐵1,… , 퐵퐾 )
′ we note that
√
퐽 (휃̂ − 휃)
푑
∼ MVN(0,−1(휃)(휃)−1(휃)) (1)
as 퐽 →∞, where(휃) = 퐸{−휕푆(휃)∕휕휃′} is a block diagonal 3퐾 × 3퐾 matrix of the form
(휃) =
⎡⎢⎢⎢⎢⎢⎢⎢⎣
11(휃1) 0 … 0
0 22(휃2) … 0
⋮ ⋱ ⋮
0 퐾퐾 (휃퐾 )
⎤⎥⎥⎥⎥⎥⎥⎥⎦
where the 푘th 3 × 3 diagonal sub-matrix is given by
푘푘(휃푘) = 퐸{−휕푆푘(휃푘)∕휕휃
′
푘
} = 퐸
{
퐽∑
푗=1
푅푗푘푋푗푘푋
′
푗푘
}
= 퐽 퐸{푋푗푘푋
′
푗푘
∣ 푅푗푘 = 1}푃 (푅푗푘 = 1) ,
푘 = 1,… , 퐾 . If we let Ω푘푘 = 푃 (푋푗푘 푋
′
푗푘
|푅푗푘 = 1) be a 3 × 3 matrix, we can then write
푘푘(휃푘) = 퐽 Ω푘푘 푃 (푅푗푘 = 1) . (2)
Note that (휃) = 퐸{푆(휃)푆′(휃)} is also a 3퐾 × 3퐾 matrix. Under the assumption that the response data are missing at
random (i.e. 푅푗푘 ⟂ 푌푗푘|푋푗푘), the diagonal elements of (휃) are the covariance matrices of the score functions for 휃푘, 푘푘(휃) =
cov(푆푘(휃푘) ∣ 퐵), 푘 = 1,… , 퐾 where
푘푘(휃) = 퐸
{
퐽∑
푗=1
푅푗푘 푆푗푘(휃푘)푆
′
푗푘
(휃푘)
}
= 퐸
{
퐽∑
푗=1
푅푗푘푋푗푘푋
′
푗푘
var(퐸푗푘)
}
,
since the error terms are assumed independent of the covariates. This can then be written as
푘푘(휃) = 퐽 Ω푘푘 푃 (푅푗푘 = 1) 휎
2
푘
, 푘 = 1,… , 퐾 . (3)
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In a similar fashion we note that
푘푙(휃) = cov(푆푘(휃푘), 푆푙(휃푙) ∣ 퐵) = 퐸
{
퐽∑
푗=1
푅푗푘푅푗푙 퐸{푆푗푘(휃푘)푆
′
푗푙
(휃푙) ∣ 푋푗푘, 푋푗푙, 푅푗푘 = 푅푗푙 = 1}
}
= 퐸
{
퐽∑
푗=1
푅푗푘푅푗푙 푋푗푘푋
′
푗푙
cov(퐸푗푘, 퐸푗푙)
}
= 퐽 퐸{푋푗푘푋
′
푗푙
∣ 푅푗푘 = 푅푗푙 = 1}푃 (푅푗푘 = 푅푗푙 = 1) 휎푘푙
= 퐽 Ω푘푙 푃 (푅푗푘 = 푅푗푙 = 1) 휎푘푙
where Ω푘푙 = 퐸{푋푗푘푋
′
푗푙
|푅푗푘 = 푅푗푙 = 1} is a 3 × 3 matrix. If 푋푗푘 = 푋푗푙 as in this setting, this becomes
푘푙(휃) = cov(푆푘(휃푘), 푆푙(휃푙) ∣ 퐵) = 퐽 Ω푘푘 푃 (푅푗푘 = 푅푗푙 = 1) 휎푘푙 (4)
since Ω푘푘 = Ω푘푙 = Ω for all 푘 ≠ 푙.
If we wish to estimate the covariance of
√
퐽 (휃̂푘 − 휃푘) and
√
퐽 (휃̂푙 − 휃푙) given 퐵 we note that this has the general form
cov(
√
퐽 (휃̂푘 − 휃푘),
√
퐽 (휃̂푙 − 휃푙) ∣ 퐵) = 
−1
푘푘
(휃)퐵푘푙(휃)
−1
푙푙
(휃) .
Inserting the derived expressions gives the (푘, 푙), 3 × 3 sub-matrix of the full covariance matrix in (1) as
cov(
√
퐽 (휃̂푘 − 휃푘),
√
퐽 (휃̂푙 − 휃푙) ∣ 퐵) =
휎푘푙Ω
−1 푃 (푅푗푘 = 푅푗푙 = 1)
푃 (푅푗푘 = 1)푃 (푅푗푙 = 1)
. (5)
We estimate (5) as follows. Since 푋푗푘 = 푋푗 is available for all individuals we estimate Ω = Ω푘푘 = Ω푘푙 simply as
Ω̂ =
∑퐽
푗=1
(푋푗푘푋
′
푗푘
)∕퐽 . Moreover we estimate 푃 (푅푗푘 = 푅푗푙 = 1) empirically as 푃̂ (푅푗푘 = 푅푗푙 = 1) = 푛푘푙∕퐽 where
푛푘푙 =
∑퐽
푗=1
푅푗푘푅푗푙, and likewise let 푃̂ (푅푗푘 = 1) = 푛푘∕퐽 where 푛푘 =
∑퐽
푗=1
푅푗푘, 푘 = 1,… , 퐾 . Replacing unknown quantities
with their estimates gives
ĉov(
√
퐽 (휃̂푘 − 휃푘),
√
퐽 (휃̂푙 − 휃푙) ∣ 퐵) =
휎̂푘푙
퐽−1
∑퐽
푗=1
(푋푗푘푋
′
푗푙
)
퐽 푛푘푙
푛푘푛푙
(6)
where 휎̂푘푙 is given by (3.12).
Let 휇(훽) = 핀 훽 where 핀 is a 퐾 × 1 vector of ones and 훽 is a scalar. We then let cov{
√
퐽 (퐵̂ − 휇(훽))|퐵} = Γ where Γ is
the covariance matrix for 퐵̂ obtained by selecting the corresponding elements of (5) related to the coefficients of the exposure
variable in the 퐾 marginal least squares estimates. We aim to use cov(
√
퐽 (퐵̂ − 휇(훽))|퐵) to combine the estimates across all
responses, but we note there is an additional component of variation in the estimators of the exposure effects since the 퐵푘 terms
are themselves independent and identically distributed according to (3.2). Thus while cov(퐵̂|퐵) = 퐽−1 Γ where Γ is a 퐾 × 퐾
matrix with diagonal elements Γ푘푘 and off-diagonal elements Γ푘푙, 푙 = 1,… , 퐾 , 푘 = 1,… , 퐾 ,
var(퐵̂푘) = 퐽
−1 Γ푘푘 + 휙 , 푘 = 1,… , 퐾 , (7)
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and since 퐵푘 ⟂ 퐵푙,
cov(퐵̂푘, 퐵̂푙) = 퐽
−1 Γ푘푙 , 푘 ≠ 푙 = 1,… , 퐾 . (8)
We denote the unconditional covariance matrix for 퐵̂ as cov(퐵̂) = Ψ(휙) = 퐽−1 Γ +Δ휙 where Ψ푘푘(휙) is given by (7), Ψ푘푙(휙) is
given by (8), and Δ is a 퐾 ×퐾 identity matrix. Given an estimate of 휙, we estimate this covariance matrix by
ĉov(퐵̂) = 퐽−1 Γ̂ + Δ 휙̂ = Ψ̂(휙̂) .
